UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035184
Receipt number R000040105
Scientific Title The impact of coversion of dialysate calcium concentration from either 2.5 mEq/L or 3.0 mEq/L to 2.75 mEq/L on mineral and bone disorders in maintenance hemodialysis patients: the K4 Study
Date of disclosure of the study information 2019/01/01
Last modified on 2018/12/08 22:07:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The impact of coversion of dialysate calcium concentration from either 2.5 mEq/L or 3.0 mEq/L to 2.75 mEq/L on mineral and bone disorders in maintenance hemodialysis patients: the K4 Study

Acronym

the K4 Study

Scientific Title

The impact of coversion of dialysate calcium concentration from either 2.5 mEq/L or 3.0 mEq/L to 2.75 mEq/L on mineral and bone disorders in maintenance hemodialysis patients: the K4 Study

Scientific Title:Acronym

the K4 Study

Region

Japan


Condition

Condition

Endstage Kidney Disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the best dialysate calcium concentration in maintenance hemodialysis patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Amount of intradialytic calcium elimination

Key secondary outcomes

Serum levels of calciuim, phosphate, and parathyroid hormone


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

2.75 mEq/L calcium dialysate

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male

Key inclusion criteria

Maintenance hemodialysis patients treated with either 2.5 mEq/L or 3.0 mEq/L calcium dialysate

Key exclusion criteria

Female

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masatomo Taniguchi

Organization

Fukuoka Renal Clinic

Division name

Division of Nephrology

Zip code


Address

4-6-20 Watanabe-dori, Chuo-ku, Fukuoka 810-0004, Japan

TEL

092-761-4936

Email

ana65641@nifty.com


Public contact

Name of contact person

1st name
Middle name
Last name Masatomo Taniguchi

Organization

Fukuoka Renal Clinic

Division name

Division of Nephrology

Zip code


Address

4-6-20 Watanabe-dori, Chuo-ku, Fukuoka 810-0004, Japan

TEL

092-761-4936

Homepage URL


Email

ana65641@nifty.com


Sponsor or person

Institute

Fukuoka Renal Clinic

Institute

Department

Personal name



Funding Source

Organization

Fukuoka Renal Clinic, Japan Red Cross Fukuoka Hospital, Steel Memorial Yawata Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Japanese Red Cross Fukuoka Hospital, Steel Memorial Yawata Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

2012-10

Org. issuing International ID_1

Fukuoka Red Cross Hospital

Study ID_2

24-12

Org. issuing International ID_2

Steel Memorial Yawata Hospital

IND to MHLW



Institutions

Institutions

福岡赤十字病院(福岡県),製鉄記念八幡病院(福岡県)


Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Conversion of dialysate calcium concentration from 2.5 mEq/L to 2.75 mEq/L decreased intradialytic calcium elimination, while conversion of dialysate calcium concentration from 3.0 mEq/L to 2.75 mEq/L decreaed intradialytic calcium loading in maintenance hemodialysis patients

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 12 Month 01 Day

Last follow-up date

2018 Year 08 Month 31 Day

Date of closure to data entry

2018 Year 09 Month 01 Day

Date trial data considered complete

2018 Year 10 Month 31 Day

Date analysis concluded

2018 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2018 Year 12 Month 08 Day

Last modified on

2018 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040105


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name